Every September, Apple’s product launch is treated like a cultural event. And this year was no different.
At its “Awe-Dropping” event on September 9th, Apple unveiled sleeker iPhones, new AirPods, and its latest generation of Apple Watches. As always, the company leaned on health and wellness features to make its wearables stand out.
The announcements sound impressive:
- Blood-pressure alerts on the Apple Watch Series 11.
- A Sleep Score that combines multiple biometrics to assess rest quality.
- In-ear heart rate monitoring with AirPods Pro 3.
- Even the budget Watch SE 3 now offers sleep apnea detection and ovulation tracking.
It’s an expansion of Apple’s decade-long narrative of positioning its devices not just as consumer gadgets but as health companions.
But here’s the real question: do these updates truly move the needle for healthtech, or are they incremental tweaks meant to keep the story alive?
Let’s dig in!
What are the latest Apple healthtech updates?
At the “Awe-Dropping” event, Apple launched the iPhone 17 line, Apple Watch Series 11, Ultra 3, SE 3, and AirPods Pro 3. Here are the key health updates revealed across the lineup:
Hypertension (blood-pressure) alerts
The new Apple Watch Series 11 introduces blood-pressure monitoring via an optical heart sensor and an algorithm that analyzes 30 days of data to flag potential hypertension. It’s Apple’s first wearable to offer such a feature, with FDA clearance expected soon.
Sleep score and expanded health insights
A new Sleep Score feature gauges sleep quality using heart rate, wrist temperature, blood oxygen, and respiration metrics. This will also roll out to older devices (Series 9, Ultra 2, SE 2) via watchOS 26 from September 15.
Budget-friendly model upgrades
SE 3, Apple’s budget-friendly watch model, also got new health features like sleep apnea detection, temperature sensing, and ovulation tracking.
In-ear heart-rate sensing
AirPods Pro 3 has an in-ear heart rate sensor (PPG technology). This will enable heart rate and calorie burn tracking, integrating seamlessly with the iPhone’s Fitness app via a new Workout Buddy feature.
iPhone as power hub
iPhones will be the centre of everything. The iOS 26 will tie the entire ecosystem together, powering features across Watch and AirPods.
A closer look at the “Breakthroughs”
The blood-pressure feature
This isn’t a cuffless blood-pressure monitor in the medical sense. It doesn’t provide exact readings but instead issues alerts when your baseline metrics suggest potential hypertension.
This update generated the biggest headlines and the most skepticism.
This feature has drawn equal amounts of excitement and caution. Apple VP of Health Sumbul Desai said the feature was trained on data from more than 100,000 people, and expects it will notify over one million users with undiagnosed hypertension in the first. But she admitted it “won’t detect all instances of hypertension.”
Experts see both potential and pitfalls. In conversation with Stat News, UCSF cardiologist Sanket Dhruva said he was “enthusiastic about the possibilities,” but questioned whether the feature will align with medical standards, which require patients to be at rest before a proper reading. With the Apple Watch, that might not be possible.
Yale’s Rohan Khera (Stat News) noted the feature could help younger people who rarely seek medical care. But the possibilities of flagging false positives may lead to unnecessary stress. Similarly, flagging false negatives could lead to false reassurance.
Industry analysts like Thomas Hagemeijer go further. Based on his own experience with continuous blood-pressure wearables, he argues calibration is often unreliable and can even penalise healthy behavior, like exercise.
His broader point is that continuous monitoring may not always be practical. Strategic, periodic checks might give more meaningful insights. Apple’s alert system fits somewhere in between—a useful awareness tool, but far from a clinical replacement for a $20 cuff.
We feel it’s helpful, but more of a screening nudge than a diagnostic breakthrough. It keeps Apple in regulatory-safe waters while giving users something new to talk about.
The sleep score
Apple’s Sleep Score integrates multiple metrics for a holistic view of rest. But many rivals, from Fitbit to Oura, already offer similar scoring systems. Apple’s edge is ecosystem integration and scale, not innovation. It may push millions more people to take sleep seriously, but it’s not a radical leap for digital health.
The AirPods as health devices
Perhaps the boldest move came with the AirPods Pro 3. Heart-rate sensing is a clever use of ear-based PPG sensors.
By embedding sensors in a product used by hundreds of millions daily, Apple lowers the barrier to health tracking. Users can monitor heart rate and track calorie burn without changing habits.
For consumers, it’s health insights without extra effort.
For Apple, it’s strategic. More data into HealthKit, stronger ecosystem lock-in, and new opportunities for healthcare partnerships.
As Hagemeijer puts it, the earbud form factor taps into “passive health monitoring” — frictionless, always-on, and embedded in daily life. The opportunity is massive, but so are the stakes around accuracy, privacy, and data transparency.
However, it’s more of a lifestyle fitness tool than a clinical innovation. The “Workout Buddy” branding highlights that it’s about engagement and gamification, not diagnosis.
Why Apple plays it this way
Apple’s health strategy has always been cautious. Move step by step, emphasize wellness, and only dip into medical-grade features once the regulatory path is clear.
The company avoids overpromising and instead packages small steps as big wins. This also means progress can feel slow.
That measured pace is one reason critics argue Apple hasn’t delivered on its lofty health ambitions.
Hagemeijer notes that despite Tim Cook’s 2019 prediction that Apple’s “greatest contribution to mankind will be in health,” the company still lags peers like Nvidia, Microsoft, and Google in healthcare impact.
The bottom line
Apple hasn’t reinvented healthtech in 2025. What it has done is:
- Mainstream preventive health by nudging millions toward awareness of hypertension, sleep, and fitness
- Lower adoption barriers by embedding sensors in everyday devices like AirPods
- Build data foundations that could enable bigger moves in chronic disease management down the line
But the limitations are real. Wearables alone can’t solve healthcare’s toughest problems. Apple’s virtual-first approach lacks physical touchpoints, and premium pricing keeps many of these tools out of reach for broader populations.
So, has Apple disappointed healthtech? Not exactly.
While this wasn’t the moonshot moment many hoped for, like non-invasive glucose monitoring or truly accurate cuffless blood pressure, Apple’s updates still matter. They are normalising preventive health at scale.
It nudges public awareness forward, which is not insignificant. But in terms of pure healthtech innovation, the updates are incremental rather than groundbreaking.
For the industry, this is both a strength and a limitation. Apple makes preventive health cool, but the heavy lifting of genuine clinical breakthroughs is still being done elsewhere—in startups, research labs and regulated devices.
-By Jhanvi Shah and the AHT Team
